1,303
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Low-dose cyclooxygenase-2 (COX-2) inhibitor celecoxib plays a protective role in the rat model of neonatal necrotizing enterocolitis

Pages 7223-7234 | Received 16 Aug 2021, Accepted 09 Sep 2021, Published online: 21 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (4)

Xiaohan Hu, Hansi Liang, Fang Li, Rui Zhang, Yanbo Zhu, Xueping Zhu & Yunyun Xu. (2024) Necrotizing enterocolitis: current understanding of the prevention and management. Pediatric Surgery International 40:1.
Crossref
Mitchell M. Won, Georgi D. Mladenov, Steven L. Raymond, Faraz A. Khan & Andrei Radulescu. (2023) What animal model should I use to study necrotizing enterocolitis?. Seminars in Pediatric Surgery 32:3, pages 151313.
Crossref
Dabin Huang, Ping Wang, Juncao Chen, Yanbin Li, Mingwei Zhu, Yaping Tang & Wei Zhou. (2022) Selective targeting of MD2 attenuates intestinal inflammation and prevents neonatal necrotizing enterocolitis by suppressing TLR4 signaling. Frontiers in Immunology 13.
Crossref
Heena Khan, Kunal Sharma, Amit Kumar, Amarjot Kaur & Thakur Gurjeet Singh. (2022) Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury. Inflammation Research 71:3, pages 277-292.
Crossref